75 related articles for article (PubMed ID: 22989913)
21. Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure.
Ai X; Curran JW; Shannon TR; Bers DM; Pogwizd SM
Circ Res; 2005 Dec; 97(12):1314-22. PubMed ID: 16269653
[TBL] [Abstract][Full Text] [Related]
22. Discovery of potent and selective inhibitors of calmodulin-dependent kinase II (CaMKII).
Koltun DO; Parkhill EQ; Kalla R; Perry TD; Elzein E; Li X; Simonovich SP; Ziebenhaus C; Hansen TR; Marchand B; Hung WK; Lagpacan L; Hung M; Aoyama RG; Murray BP; Perry JK; Somoza JR; Villaseñor AG; Pagratis N; Zablocki JA
Bioorg Med Chem Lett; 2018 Feb; 28(3):541-546. PubMed ID: 29254643
[TBL] [Abstract][Full Text] [Related]
23. Curcumin Inhibits Neuronal Loss in the Retina and Elevates Ca²⁺/Calmodulin-Dependent Protein Kinase II Activity in Diabetic Rats.
Li J; Wang P; Zhu Y; Chen Z; Shi T; Lei W; Yu S
J Ocul Pharmacol Ther; 2015 Nov; 31(9):555-62. PubMed ID: 26207889
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and structure based optimization of 2-(4-phenoxybenzoyl)-5-hydroxyindole as a novel CaMKII inhibitor.
Komiya M; Asano S; Koike N; Koga E; Igarashi J; Nakatani S; Isobe Y
Bioorg Med Chem; 2012 Dec; 20(23):6840-7. PubMed ID: 23088910
[TBL] [Abstract][Full Text] [Related]
25. Curcumin Modulates the NMDA Receptor Subunit Composition Through a Mechanism Involving CaMKII and Ser/Thr Protein Phosphatases.
Mallozzi C; Parravano M; Gaddini L; Villa M; Pricci F; Malchiodi-Albedi F; Matteucci A
Cell Mol Neurobiol; 2018 Aug; 38(6):1315-1320. PubMed ID: 29846839
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of novel benzo-fused heteroaryl derivatives as Ca²⁺/calmodulin-dependent protein kinase II inhibitors.
Komiya M; Asano S; Koike N; Koga E; Igarashi J; Nakatani S; Isobe Y
Chem Pharm Bull (Tokyo); 2013; 61(10):1094-7. PubMed ID: 24088703
[TBL] [Abstract][Full Text] [Related]
27. Oral curcumin has anti-arthritic efficacy through somatostatin generation via cAMP/PKA and Ca(2+)/CaMKII signaling pathways in the small intestine.
Yang Y; Wu X; Wei Z; Dou Y; Zhao D; Wang T; Bian D; Tong B; Xia Y; Xia Y; Dai Y
Pharmacol Res; 2015; 95-96():71-81. PubMed ID: 25836921
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a selective CaMKII peptide inhibitor.
Gomez-Monterrey I; Sala M; Rusciano MR; Monaco S; Maione AS; Iaccarino G; Tortorella P; D'Ursi AM; Scrima M; Carotenuto A; De Rosa G; Bertamino A; Vernieri E; Grieco P; Novellino E; Illario M; Campiglia P
Eur J Med Chem; 2013 Apr; 62():425-34. PubMed ID: 23395965
[TBL] [Abstract][Full Text] [Related]
29. Dual mechanism of a natural CaMKII inhibitor.
Vest RS; Davies KD; O'Leary H; Port JD; Bayer KU
Mol Biol Cell; 2007 Dec; 18(12):5024-33. PubMed ID: 17942605
[TBL] [Abstract][Full Text] [Related]
30. Roles of calcium/calmodulin-dependent kinase II in long-term memory formation in crickets.
Mizunami M; Nemoto Y; Terao K; Hamanaka Y; Matsumoto Y
PLoS One; 2014; 9(9):e107442. PubMed ID: 25215889
[TBL] [Abstract][Full Text] [Related]
31. N-(Phenoxyalkyl)amides as MT(1) and MT(2) ligands: antioxidant properties and inhibition of Ca(2+)/CaM-dependent kinase II.
Carocci A; Catalano A; Bruno C; Lovece A; Roselli MG; Cavalluzzi MM; De Santis F; De Palma A; Rusciano MR; Illario M; Franchini C; Lentini G
Bioorg Med Chem; 2013 Feb; 21(4):847-51. PubMed ID: 23332368
[TBL] [Abstract][Full Text] [Related]
32. CaMKII in cerebral ischemia.
Coultrap SJ; Vest RS; Ashpole NM; Hudmon A; Bayer KU
Acta Pharmacol Sin; 2011 Jul; 32(7):861-72. PubMed ID: 21685929
[TBL] [Abstract][Full Text] [Related]
33. Improving a natural CaMKII inhibitor by random and rational design.
Coultrap SJ; Bayer KU
PLoS One; 2011; 6(10):e25245. PubMed ID: 21984908
[TBL] [Abstract][Full Text] [Related]
34. The role of Ca
Rostas JAP; Spratt NJ; Dickson PW; Skelding KA
Neurochem Int; 2017 Jul; 107():33-42. PubMed ID: 28153786
[TBL] [Abstract][Full Text] [Related]
35. One pot synthesis, structural and spectral analysis of some symmetrical curcumin analogues catalyzed by calcium oxide under microwave irradiation.
Elavarasan S; Bhakiaraj D; Chellakili B; Elavarasan T; Gopalakrishnan M
Spectrochim Acta A Mol Biomol Spectrosc; 2012 Nov; 97():717-21. PubMed ID: 22885932
[TBL] [Abstract][Full Text] [Related]
36. The chemosensitizing agent lubeluzole binds calmodulin and inhibits Ca(2+)/calmodulin-dependent kinase II.
Bruno C; Cavalluzzi MM; Rusciano MR; Lovece A; Carrieri A; Pracella R; Giannuzzi G; Polimeno L; Viale M; Illario M; Franchini C; Lentini G
Eur J Med Chem; 2016 Jun; 116():36-45. PubMed ID: 27043269
[TBL] [Abstract][Full Text] [Related]
37. CaMKII inhibition in heart failure makes jump to human.
Bers DM
Circ Res; 2010 Oct; 107(9):1044-6. PubMed ID: 21030721
[No Abstract] [Full Text] [Related]
38. Monocarbonyl curcumin analogues: heterocyclic pleiotropic kinase inhibitors that mediate anticancer properties.
Brown A; Shi Q; Moore TW; Yoon Y; Prussia A; Maddox C; Liotta DC; Shim H; Snyder JP
J Med Chem; 2013 May; 56(9):3456-66. PubMed ID: 23550937
[TBL] [Abstract][Full Text] [Related]
39. On the brain of a crustacean: a morphological analysis of CaMKII expression and its relation to sensory and motor pathways.
Ammar D; Nazari EM; Müller YM; Allodi S
PLoS One; 2013; 8(5):e64855. PubMed ID: 23741406
[TBL] [Abstract][Full Text] [Related]
40. Oxidative CaMKII as a potential target for inflammatory disease (Review).
Qu J; Mei Q; Niu R
Mol Med Rep; 2019 Aug; 20(2):863-870. PubMed ID: 31173191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
